skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,274,116  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Material Type:
Article
Add to My Research

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Annals of oncology, 2018-02, Vol.29 (2), p.405-417 [Peer Reviewed Journal]

2017 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx651 ;PMID: 29092024

Full text available

2
Relationships between the age of 25,445 men attending infertility clinics and sperm chromatin structure assay (SCSA®) defined sperm DNA and chromatin integrity
Material Type:
Article
Add to My Research

Relationships between the age of 25,445 men attending infertility clinics and sperm chromatin structure assay (SCSA®) defined sperm DNA and chromatin integrity

Fertility and sterility, 2020-08, Vol.114 (2), p.311-320 [Peer Reviewed Journal]

2020 American Society for Reproductive Medicine ;Copyright © 2020 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. ;ISSN: 0015-0282 ;EISSN: 1556-5653 ;DOI: 10.1016/j.fertnstert.2020.03.028 ;PMID: 32653083

Full text available

3
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
Material Type:
Article
Add to My Research

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results

Breast cancer research and treatment, 2017-02, Vol.161 (3), p.575-586 [Peer Reviewed Journal]

The Author(s) 2016 ;COPYRIGHT 2017 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, 2017. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-016-4085-4 ;PMID: 28008555 ;CODEN: BCTRD6

Full text available

4
Antioxidants for male subfertility
Material Type:
Article
Add to My Research

Antioxidants for male subfertility

Cochrane database of systematic reviews, 2022-05, Vol.2022 (5), p.CD007411 [Peer Reviewed Journal]

Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD007411.pub5 ;PMID: 35506389

Full text available

5
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Material Type:
Article
Add to My Research

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

Breast cancer research and treatment, 2013-01, Vol.137 (2), p.465-470 [Peer Reviewed Journal]

Springer Science+Business Media New York 2012 ;2014 INIST-CNRS ;COPYRIGHT 2013 Springer ;Springer Science+Business Media New York 2013 ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-012-2355-3 ;PMID: 23224235 ;CODEN: BCTRD6

Full text available

6
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Material Type:
Article
Add to My Research

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3138-3149 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.00147 ;PMID: 32678716

Full text available

7
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
Material Type:
Article
Add to My Research

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

British journal of cancer, 2019-12, Vol.121 (12), p.991-1000 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0619-y ;PMID: 31719684

Full text available

8
Urine bisphenol-A (BPA) level in relation to semen quality
Material Type:
Article
Add to My Research

Urine bisphenol-A (BPA) level in relation to semen quality

Fertility and sterility, 2011-02, Vol.95 (2), p.625-630.e4 [Peer Reviewed Journal]

American Society for Reproductive Medicine ;2011 American Society for Reproductive Medicine ;2015 INIST-CNRS ;Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. ;ISSN: 0015-0282 ;EISSN: 1556-5653 ;DOI: 10.1016/j.fertnstert.2010.09.026 ;PMID: 21035116 ;CODEN: FESTAS

Full text available

9
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Material Type:
Article
Add to My Research

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Cancer cell, 2018-09, Vol.34 (3), p.427-438.e6 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2018.08.008 ;PMID: 30205045

Full text available

10
Relationship between semen production and medical comorbidity
Material Type:
Article
Add to My Research

Relationship between semen production and medical comorbidity

Fertility and sterility, 2015-01, Vol.103 (1), p.66-71 [Peer Reviewed Journal]

American Society for Reproductive Medicine ;2015 American Society for Reproductive Medicine ;Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. ;ISSN: 0015-0282 ;EISSN: 1556-5653 ;DOI: 10.1016/j.fertnstert.2014.10.017 ;PMID: 25497466

Full text available

11
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Material Type:
Article
Add to My Research

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2141-2148 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.70.8297 ;PMID: 28291390

Full text available

12
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.743-754 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30313-3 ;PMID: 28526538

Full text available

13
Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer
Material Type:
Article
Add to My Research

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer

Breast cancer research and treatment, 2018-05, Vol.169 (1), p.105-113 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2018 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-018-4661-x ;PMID: 29335925

Full text available

14
Genomic Characterization of de novo Metastatic Breast Cancer
Material Type:
Article
Add to My Research

Genomic Characterization of de novo Metastatic Breast Cancer

Clinical cancer research, 2021-02, Vol.27 (4), p.1105-1118 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-1720 ;PMID: 33293374

Full text available

15
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30312-1 ;PMID: 28526536

Full text available

16
Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States
Material Type:
Article
Add to My Research

Comparison of the Natural History of Genital HPV Infection among Men by Country: Brazil, Mexico, and the United States

Cancer epidemiology, biomarkers & prevention, 2017-07, Vol.26 (7), p.1043-1052 [Peer Reviewed Journal]

2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research, Inc. Jul 2017 ;ISSN: 1055-9965 ;EISSN: 1538-7755 ;DOI: 10.1158/1055-9965.EPI-17-0040 ;PMID: 28446543

Full text available

17
Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank
Material Type:
Article
Add to My Research

Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank

JNCI : Journal of the National Cancer Institute, 2020-09, Vol.112 (9), p.893-901 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djz241 ;PMID: 31899501

Full text available

18
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Material Type:
Article
Add to My Research

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

The lancet oncology, 2012-04, Vol.13 (4), p.e148-e160 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2012 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(11)70383-7 ;PMID: 22469125 ;CODEN: LANCAO

Full text available

19
Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study
Material Type:
Article
Add to My Research

Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study

Annals of oncology, 2018-01, Vol.29 (1), p.154-161 [Peer Reviewed Journal]

2018 European Society for Medical Oncology ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx505 ;PMID: 29045554

Full text available

20
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer
Material Type:
Article
Add to My Research

Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.407-415 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Jan 15, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-16-0362 ;PMID: 27342400

Full text available

Results 1 - 20 of 1,274,116  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,178,595)

Refine My Results

Creation Date 

From To
  1. Before 1964  (108)
  2. 1964 To 1978  (42,236)
  3. 1979 To 1993  (140,750)
  4. 1994 To 2009  (456,130)
  5. After 2009  (635,509)
  6. More options open sub menu

Subject 

  1. Humans  (1,273,378)
  2. Male  (1,273,232)
  3. Female  (1,128,133)
  4. Science & Technology  (1,082,058)
  5. Middle Aged  (1,067,501)
  6. Life Sciences & Biomedicine  (1,045,288)
  7. Adult  (769,806)
  8. Aged, 80 And Over  (418,604)
  9. Biological And Medical Sciences  (359,335)
  10. Medical Sciences  (343,521)
  11. Adolescent  (252,747)
  12. Retrospective Studies  (194,388)
  13. Risk Factors  (175,354)
  14. Treatment Outcome  (174,501)
  15. Young Adult  (166,265)
  16. Surgery  (144,998)
  17. Cardiovascular System & Cardiology  (128,924)
  18. Prospective Studies  (127,373)
  19. Follow-Up Studies  (118,720)
  20. More options open sub menu

Language 

  1. English  (1,232,678)
  2. Japanese  (193,181)
  3. Spanish  (14,629)
  4. Portuguese  (14,585)
  5. German  (10,254)
  6. French  (7,482)
  7. Chinese  (1,848)
  8. Polish  (1,494)
  9. Russian  (1,327)
  10. Norwegian  (1,243)
  11. Italian  (1,184)
  12. Korean  (977)
  13. Turkish  (867)
  14. Swedish  (728)
  15. Czech  (520)
  16. Serbian  (502)
  17. Ukrainian  (332)
  18. Romanian  (185)
  19. Croatian  (171)
  20. Icelandic  (126)
  21. More options open sub menu

Searching Remote Databases, Please Wait